Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Human herpes virus type 6 (HHV-6) and its in vitro effect on human immunodeficiency virus (HIV).

Literature DB >> 3225332

Human herpes virus type 6 (HHV-6) and its in vitro effect on human immunodeficiency virus (HIV).

G R Pietroboni¹, G B Harnett, T J Farr, M R Bucens.

Abstract

Human herpes virus type 6 (HHV-6) was isolated from the peripheral blood lymphocytes of a patient infected with human immunodeficiency virus (HIV). Antibodies to this herpes virus were found to be widespread among adults and children in Western Australia. Co-infection studies indicated that HIV replication was inhibited by the presence of HHV-6.

Entities: Species

Mesh：

Substances：
Antibodies, Viral

Year: 1988 PMID： 3225332 PMCID： PMC1141765 DOI： 10.1136/jcp.41.12.1310

Source DB: PubMed Journal: J Clin Pathol ISSN： 0021-9746 Impact factor: 3.411

8 in total

1. Genomic analysis of the human B-lymphotropic virus (HBLV).

Authors: S F Josephs; S Z Salahuddin; D V Ablashi; F Schachter; F Wong-Staal; R C Gallo
Journal: Science Date: 1986-10-31 Impact factor: 47.728

2. HBLV (or HHV-6) in human cell lines.

Authors: D V Ablashi; S Z Salahuddin; S F Josephs; F Imam; P Lusso; R C Gallo; C Hung; J Lemp; P D Markham
Journal: Nature Date: 1987 Sep 17-23 Impact factor: 49.962

3. Enhancement of infectivity of murine cytomegalovirus in vitro by centrifugal inoculation.

Authors: J E Osborn; D L Walker
Journal: J Virol Date: 1968-09 Impact factor: 5.103

4. Isolation of human herpesvirus 6 from saliva.

Authors: G R Pietroboni; G B Harnett; M R Bucens; R W Honess
Journal: Lancet Date: 1988-05-07 Impact factor: 79.321

5. Age prevalence of antibody to human herpesvirus 6.

Authors: M Briggs; J Fox; R S Tedder
Journal: Lancet Date: 1988-05-07 Impact factor: 79.321

6. A novel lymphotropic herpesvirus.

Authors: R S Tedder; M Briggs; C H Cameron; R Honess; D Robertson; H Whittle
Journal: Lancet Date: 1987-08-15 Impact factor: 79.321

7. Human B-lymphotropic virus in Germany.

Authors: G R Krueger; D V Ablashi
Journal: Lancet Date: 1987-09-19 Impact factor: 79.321

8. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors: S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal: Science Date: 1986-10-31 Impact factor: 47.728

8 in total

10 in total

Review 1. Human herpesvirus 6.

Authors: D K Braun; G Dominguez; P E Pellett
Journal: Clin Microbiol Rev Date: 1997-07 Impact factor: 26.132

2. Artificially inserting a reticuloendotheliosis virus long terminal repeat into a bacterial artificial chromosome clone of Marek's disease virus (MDV) alters expression of nearby MDV genes.

Authors: Taejoong Kim; Jody Mays; Aly Fadly; Robert F Silva
Journal: Virus Genes Date: 2011-02-22 Impact factor: 2.332

3. Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures.

Authors: H Asada; V Klaus-Kovtun; H Golding; S I Katz; A Blauvelt
Journal: J Virol Date: 1999-05 Impact factor: 5.103

4. The distribution of antibodies to HHV-6 compared with other herpesviruses in young children.

Authors: T J Farr; G B Harnett; G R Pietroboni; M R Bucens
Journal: Epidemiol Infect Date: 1990-12 Impact factor: 2.451

5. Isolation of HHV-6-related virus from children affected by infectious syndrome.

Authors: M Portolani; C Cermelli; P Pietrosemoli; M Pecorari; F Farabegoli; G B Cavazzuti; M F Bertolani; A Micheli
Journal: Arch Virol Date: 1990 Impact factor: 2.574

6. Effect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers.

Authors: A Linde; E Fridell; H Dahl; J Andersson; P Biberfeld; B Wahren
Journal: J Clin Microbiol Date: 1990-02 Impact factor: 5.948

10. Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds.

Authors: A Akesson-Johansson; J Harmenberg; B Wahren; A Linde
Journal: Antimicrob Agents Chemother Date: 1990-12 Impact factor: 5.191